Ivermectin topical - Galderma

Drug Profile

Ivermectin topical - Galderma

Alternative Names: CD 5024; Soolantra

Latest Information Update: 21 Aug 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Galderma
  • Class Antiparasitics; Macrolides
  • Mechanism of Action Chloride channel agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Rosacea
  • Phase II Acne vulgaris; Atopic dermatitis

Most Recent Events

  • 17 Jul 2017 Galderma initiates litigation against Perrigo over ANDA submission in USA
  • 26 Jun 2017 Galderma completes phase II trials in Atopic dermatitis in Canada (NCT03250624)
  • 02 Nov 2016 Galderma completed a phase II trial in Acne vulgaris in Germany (Topical) (EudraCT2016-000063-16)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top